![](/img/cover-not-exists.png)
Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine ?
Peter J. Goadsby, Karen L. HoskinVolume:
67
Year:
1996
Language:
english
Pages:
360
DOI:
10.1016/0304-3959(96)03118-1
File:
PDF, 540 KB
english, 1996